Andrew Cannon

IDH2 R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma

Chao Wang, Timothy W. McKeithan, Qiang Gong et al. · Blood · 2015 · 248 citations · Full text

Medicine, Hematology, Oncology +13

Recurrent activating mutations of CD28 in peripheral T-cell lymphomas

Joseph Rohr, Shuangping Guo, Jiandong Huo et al. · Leukemia · 2015 · 128 citations

Life Sciences, Hematology, Immunology +12

Advanced pancreatic cancer: a meta-analysis of clinical trials over thirty years

Bradley R. Hall, Andrew Cannon, Pranita Atri et al. · Oncotarget · 2018 · 46 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Phosphorylation of Cx43 residue Y313 by Src contributes to blocking the interaction with Drebrin and disassembling gap junctions

Zheng Li, Hanjun Li, Andrew Cannon et al. · Journal of Molecular and Cellular Cardiology · 2018 · 33 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

Utilizing cell line-derived organoids to evaluate the efficacy of a novel LIFR-inhibitor, EC359 in targeting pancreatic tumor stroma

Bradley R. Hall, Andrew Cannon, Christopher M. Thompson et al. · Genes & Cancer · 2018 · 32 citations · Full text

Medicine, Cell Biology, Oncology +17